{"id":942887,"date":"2026-05-07T02:48:26","date_gmt":"2026-05-07T02:48:26","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/942887\/"},"modified":"2026-05-07T02:48:26","modified_gmt":"2026-05-07T02:48:26","slug":"lilly-commits-additional-4-5-billion-across-indiana-manufacturing-sites-opens-first-dedicated-genetic-medicine-facility","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/942887\/","title":{"rendered":"Lilly commits additional $4.5 billion across Indiana manufacturing sites, opens first dedicated genetic medicine facility"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\">&#8220;This expansion reflects the strength of a long-standing partnership between Lilly and the state of Indiana \u2013 one that continues to deliver real results for Hoosiers,&#8221; said Governor Mike Braun. &#8220;With this investment in Lebanon and across the state, Indiana is reinforcing its position as a prime destination for life sciences and advanced manufacturing, spanning innovation, production and global distribution. Together, we are helping lead the future of medicine while creating high-quality jobs and new opportunities for our communities.&#8221;<\/p>\n<p class=\"yf-1fy9kyt\">Lilly&#8217;s manufacturing investment extends well beyond its campus walls. According to a report that will be released next week by Indiana University&#8217;s Kelley School of Business, Indiana Business Research Center, &#8220;Measuring Lilly&#8217;s Economic and Civic Contributions in Indiana,&#8221; Lilly accounts for 70% of Indiana&#8217;s pharmaceutical GDP and every Lilly job supports more than two additional jobs across the state. Further, the company estimates that for every dollar it spends in the area, up to four dollars in additional local economic activity is generated.<\/p>\n<p class=\"yf-1fy9kyt\">&#8220;Findings from the Kelley School&#8217;s Indiana Business Research Center report demonstrate Lilly&#8217;s investments in Indiana are transforming communities across the state in meaningful and far-reaching ways,&#8221;\u00a0IU President Pamela Whitten said. &#8220;Lilly&#8217;s sustained investments since 2020 underscore the growing strength of Indiana&#8217;s life sciences sector. Progress at this scale is possible only through robust partnerships, and Indiana University is moving with purpose alongside Lilly to advance innovation that improves health, prepares a world-class workforce and drives economic vitality.&#8221;<\/p>\n<p class=\"yf-1fy9kyt\">Lilly&#8217;s U.S. capital expansion commitments since 2020 total more than $50 billion, investments made possible thanks to policies that promote domestic manufacturing. The company plans to break ground on several of its recently announced U.S. manufacturing sites this year.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Optional Quote for Media:<\/b><\/p>\n<p class=\"yf-1fy9kyt\">&#8220;Today&#8217;s announcement is a milestone for the City of Lebanon, a testament to the strength of our local workforce, and the vitality of our city,&#8221; said Matt Gentry, Mayor of Lebanon. &#8220;Lilly has been an incredible partner, and their decision to further invest in our community ensures that Lebanon will remain at the forefront of the pharmaceutical industry for decades to come. We look forward to the continued growth and the positive impact this will have on our city and the entire state of Indiana.&#8221;<\/p>\n<p class=\"yf-1fy9kyt\"><b>About<\/b>\u00a0<b>Zepbound<\/b>\u00ae\u00a0<b>(tirzepatide) injection<\/b>\u00a0<br \/>Zepbound\u00ae\u00a0(tirzepatide)\u00a0is the first and only dual GIP (glucose-dependent insulinotropic polypeptide) and\u00a0GLP-1\u00a0(glucagon-like peptide-1) receptor agonist obesity medication.\u00a0Zepbound\u00a0tackles an underlying cause of excess weight. It reduces appetite and how much you eat.\u00a0Zepbound\u00a0is\u00a0indicated\u00a0for adults with obesity, or some adults who are overweight\u00a0and also\u00a0have at least one weight-related medical problem, to lose weight and keep it off. Additionally,\u00a0Zepbound\u00a0is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity.\u00a0Zepbound\u00a0should be used with a\u00a0reduced-calorie\u00a0diet and increased physical activity.<\/p>\n<p class=\"yf-1fy9kyt\"><b>About<\/b>\u00a0<b>Mounjaro<\/b><b>\u00ae<\/b> <b>(tirzepatide) injection <br \/><\/b>Mounjaro\u00ae\u00a0(tirzepatide) is an injectable medicine for adults and children 10 years of age and older with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). As the first and only FDA-approved GIP and GLP-1 receptor agonist,\u00a0Mounjaro\u00a0is a single molecule that activates the body&#8217;s receptors for GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). It is not known if\u00a0Mounjaro\u00a0is safe and effective for use in children under 10 years of age.<\/p>\n<p class=\"yf-1fy9kyt\"><b>About<\/b>\u00a0<b>Foundayo<\/b>\u2122\u00a0<b>(orforglipron)<\/b>\u00a0<br \/>Foundayo\u2122\u00a0(orforglipron) is FDA-approved for adults with obesity, or some adults with overweight who also have weight-related medical problems to reduce excess body weight and\u00a0maintain\u00a0weight reduction long term, alongside a reduced-calorie diet and increased physical activity.\u00a0Foundayo\u00a0is a once-daily small molecule (non-peptide) oral glucagon-like peptide-1 receptor agonist that can be taken any time of the day without restrictions on food and water intake.2\u00a0Orforglipron\u00a0was discovered by Chugai Pharmaceutical Co., Ltd. and licensed by Lilly in 2018. In addition to chronic weight management,\u00a0Foundayo\u00a0is being studied as a potential treatment for type 2 diabetes, obstructive sleep apnea, osteoarthritis knee pain, hypertension, peripheral artery\u00a0disease\u00a0and stress urinary incontinence.<\/p>\n<p class=\"yf-1fy9kyt\"><b>About retatrutide<\/b>\u00a0<br \/>Retatrutide\u00a0is an investigational once-weekly triple hormone receptor agonist.\u00a0Retatrutide\u00a0is a single molecule that activates the body&#8217;s receptors for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon. Lilly is studying\u00a0retatrutide\u00a0in several Phase 3 clinical trials to evaluate its potential efficacy and safety in obesity and overweight with at least one weight-related medical problem, type 2 diabetes, knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated\u00a0steatotic\u00a0liver disease.\u00a0Retatrutide\u00a0is an investigational molecule that is legally available only to participants in Lilly&#8217;s clinical trials.<\/p>\n<p class=\"yf-1fy9kyt\"><b>INDICATIONS AND SAFETY SUMMARY WITH WARNINGS<\/b> <br \/>Zepbound\u00ae (ZEHP-bownd) is an injectable prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with:<\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">moderate-to-severe obstructive sleep apnea (OSA) and obesity to improve their OSA.<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\">Zepbound\u00a0contains\u00a0tirzepatide and should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if\u00a0Zepbound\u00a0is safe and effective for use in children.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Warnings<\/b>\u00a0<b>&#8211;<\/b>\u00a0Zepbound\u00a0may cause tumors in the thyroid, including thyroid cancer. Watch for\u00a0possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.<\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Do not use\u00a0Zepbound\u00a0if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Do not use\u00a0Zepbound\u00a0if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Do not use\u00a0Zepbound\u00a0if you have had a serious allergic reaction to tirzepatide or any of the\u00a0ingredients in\u00a0Zepbound.<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><b>KwikPen\u00ae: Do not share your<\/b>\u00a0<b>KwikPen<\/b>\u00a0<b>with other people, even if the pen needle has been changed. <\/b>\u00a0You may give other people a serious infection or get a serious infection from them.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Zepbound<\/b>\u00a0<b>may cause serious side effects, including:<\/b><\/p>\n<p class=\"yf-1fy9kyt\"><b>Severe stomach problems<\/b>. Stomach problems, sometimes severe, have been reported in people who use\u00a0Zepbound. Tell your healthcare provider if you have stomach problems that are severe or will not go away.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Dehydration<\/b>\u00a0<b>leading<\/b>\u00a0<b>to kidney problems.<\/b>\u00a0Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Gallbladder problems.<\/b>\u00a0Gallbladder problems have happened in some people who use\u00a0Zepbound. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), or clay-colored stools.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Inflammation of<\/b>\u00a0<b>the pancreas<\/b>\u00a0<b>(pancreatitis).<\/b>\u00a0Stop using\u00a0Zepbound\u00a0and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. You may feel\u00a0the pain\u00a0from your abdomen to your back.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Serious allergic reactions.<\/b>\u00a0Stop using\u00a0Zepbound\u00a0and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching,\u00a0fainting\u00a0or feeling dizzy, or very rapid heartbeat.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Low blood sugar (hypoglycemia).<\/b>\u00a0Your risk for getting low blood sugar may be higher if you use\u00a0Zepbound\u00a0with medicines that can cause low blood sugar, such as\u00a0a sulfonylurea\u00a0or insulin.\u00a0<b>Signs and symptoms of low blood sugar<\/b>\u00a0may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness or feeling jittery.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Changes in vision in patients with type 2 diabetes.<\/b>\u00a0Tell your healthcare provider if you have changes in vision during treatment with\u00a0Zepbound.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation).<\/b>\u00a0Zepbound\u00a0may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking\u00a0Zepbound\u00a0before you are scheduled to have surgery or other procedures.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Common side effects<\/b> <br \/>The most common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn. These are not all the possible side effects of Zepbound. Talk to your healthcare provider about any side effect that bothers you or doesn&#8217;t go away.<\/p>\n<p class=\"yf-1fy9kyt\">Tell your doctor if you have any side effects.\u00a0<b>You can report side effects at 1-800-FDA-1088 or<\/b>\u00a0<a href=\"https:\/\/www.fda.gov\/safety\/medwatch-fda-safety-information-and-adverse-event-reporting-program\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:www.fda.gov\/medwatch;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;www.fda.gov\/medwatch&quot;}\" class=\"link \">www.fda.gov\/medwatch<\/a><b>.<\/b><\/p>\n<p class=\"yf-1fy9kyt\"><b>Before using<\/b>\u00a0<b> Zepbound<\/b><\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Your healthcare provider should show you how to use<\/b>\u00a0<b>Zepbound<\/b>\u00a0<b>before you use it for the first time.<\/b><\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Talk to your healthcare provider about low blood sugar and how to manage it. Tell<\/b>\u00a0<b>your <\/b>\u00a0<b>healthcare<\/b>\u00a0<b>provider if you are taking medicines to treat diabetes including<\/b>\u00a0<b>an insulin<\/b>\u00a0<b>or <\/b> <b>sulfonylurea.<\/b><\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>If you take birth control pills by mouth, talk to your healthcare provider before you use<\/b>\u00a0<b>Zepbound. Birth control pills may not work as well while using<\/b>\u00a0<b>Zepbound.<\/b>\u00a0Your healthcare\u00a0provider may recommend another type of birth control for 4 weeks after you start\u00a0Zepbound\u00a0and for 4 weeks after each increase in your dose of\u00a0Zepbound.<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><b>Review these questions with your healthcare provider:<\/b> <br \/>\u2751 Do you have other medical conditions, including problems with your pancreas, or\u00a0severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food? <br \/>\u2751 Do you take diabetes medicines, such as insulin or\u00a0sulfonylureas? <br \/>\u2751 Do you have a history of diabetic retinopathy? <br \/>\u2751 Are you scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)? <br \/>\u2751 Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements? <br \/>\u2751 Are you pregnant, plan to become pregnant,\u00a0breastfeeding, or plan to breastfeed?\u00a0Zepbound\u00a0may harm your unborn baby. Tell your healthcare provider if you become pregnant while using\u00a0Zepbound.\u00a0Zepbound\u00a0may pass into your breast milk. You should talk with your\u00a0healthcare provider about the best way to feed your baby while using\u00a0Zepbound.<\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Pregnancy Exposure Registry:<\/b>\u00a0There will be a pregnancy exposure registry for women who\u00a0have taken\u00a0Zepbound\u00a0during pregnancy. The purpose of this registry is to collect information\u00a0about\u00a0the health\u00a0of you and\u00a0your baby. Talk to your healthcare provider about how you can\u00a0take\u00a0part in this registry, or you may contact Lilly at 1-800-LillyRx (1-800-545-5979).<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><b>How to take<\/b><\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Read the Instructions for Use that come with\u00a0Zepbound.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Use\u00a0Zepbound\u00a0exactly as your healthcare provider says.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Use\u00a0Zepbound\u00a0with a\u00a0reduced-calorie\u00a0diet and increased physical activity.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Inject\u00a0Zepbound\u00a0under the skin (subcutaneously) of your stomach (abdomen), thigh, or <br \/>have another person inject in the back of the upper arm.\u00a0<b>Do not<\/b>\u00a0inject ZEPBOUND into a muscle (intramuscularly) or vein (intravenously).<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Use<\/b>\u00a0<b>Zepbound<\/b>\u00a0<b>1 time each week, at any time of the day.<\/b><\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Change (rotate) your injection site with each weekly injection.\u00a0<b>Do not<\/b>\u00a0use the same site for each injection.<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\">If you take too much\u00a0Zepbound, call your healthcare provider, call the Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.<\/p>\n<p class=\"yf-1fy9kyt\">Zepbound\u00a0is approved as a 2.5 mg,\u00a05 mg, 7.5 mg,\u00a010 mg,\u00a012.5 mg, and\u00a015 mg\u00a0injection.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Learn more<\/b> <br \/>Zepbound\u00a0is a prescription medicine. For more information, call 1-800-LillyRx (1-800-545-5979)\u00a0or go\u00a0to\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4680912-1&amp;h=1712959403&amp;u=http%3A%2F%2Fwww.zepbound.lilly.com%2F&amp;a=www.zepbound.lilly.com\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:www.zepbound.lilly.com;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;www.zepbound.lilly.com&quot;}\" class=\"link \"><b>www.zepbound.lilly.com<\/b><\/a><b>.<\/b><\/p>\n<p class=\"yf-1fy9kyt\">This summary provides basic information about\u00a0Zepbound\u00a0but does not include all information known about this medicine. Read the information that comes with your prescription each time your\u00a0prescription\u00a0is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about\u00a0Zepbound\u00a0and how to take it. Your healthcare provider is the best person to help you decide if\u00a0Zepbound is right for you.<\/p>\n<p class=\"yf-1fy9kyt\"><b>ZP CON BS 25FEB2026<\/b> <br \/>Zepbound\u00ae, its delivery device base and\u00a0KwikPen\u00ae are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.<\/p>\n<p class=\"yf-1fy9kyt\"><b>INDICATION AND SAFETY SUMMARY WITH WARNINGS<\/b> <br \/>Mounjaro\u00ae\u00a0(mown-JAHR-OH) is an injectable medicine for adults and children 10 years of age and older with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose).<\/p>\n<p class=\"yf-1fy9kyt\"><b>Warnings &#8211;<\/b>\u00a0Mounjaro\u00a0may cause tumors in the thyroid, including thyroid cancer. Watch for\u00a0possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.<\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Do not use\u00a0Mounjaro\u00a0if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Do not use\u00a0Mounjaro\u00a0if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Do not use\u00a0Mounjaro\u00a0if you are allergic to it or any of the ingredients in\u00a0Mounjaro.<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><b>Mounjaro<\/b>\u00a0<b>may cause serious side effects, including:<\/b><\/p>\n<p class=\"yf-1fy9kyt\"><b>Inflammation of<\/b>\u00a0<b>the pancreas<\/b>\u00a0<b>(pancreatitis).<\/b>\u00a0Stop using\u00a0Mounjaro\u00a0and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel\u00a0the pain\u00a0from your abdomen to your back.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Low blood sugar (hypoglycemia).<\/b>\u00a0Your risk for getting low blood sugar may be higher if you use\u00a0Mounjaro\u00a0with another medicine that can cause low blood sugar, such as\u00a0a sulfonylurea\u00a0or insulin.\u00a0<b>Signs and symptoms of low blood sugar may include<\/b>\u00a0dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness and feeling jittery.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Serious allergic reactions.<\/b>\u00a0Stop using\u00a0Mounjaro\u00a0and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching,\u00a0fainting\u00a0or feeling dizzy, and very rapid heartbeat.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Dehydration<\/b>\u00a0<b>leading<\/b>\u00a0<b>to kidney problems<\/b>. Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Severe stomach problems.<\/b>\u00a0Stomach problems, sometimes severe, have been reported in people who use\u00a0Mounjaro. Tell your healthcare provider if you have stomach problems that are severe or will not go away.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Changes in vision.<\/b>\u00a0Tell your healthcare provider if you have changes in vision during treatment with\u00a0Mounjaro.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Gallbladder problems.<\/b>\u00a0Gallbladder problems have happened in some people who use\u00a0Mounjaro. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), and clay-colored stools.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation).<\/b>\u00a0Mounjaro\u00a0may increase the chance of food getting into your lungs during surgery or other procedures. Tell all your healthcare providers that you are taking\u00a0Mounjaro\u00a0before you are scheduled to have surgery or other procedures.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Common side effects<\/b><\/p>\n<p class=\"yf-1fy9kyt\">The most common side effects of\u00a0Mounjaro\u00a0include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach (abdominal) pain. These are not all the possible side effects of\u00a0Mounjaro. Talk to your healthcare provider about any side\u00a0effect\u00a0that\u00a0bothers\u00a0you or\u00a0doesn&#8217;t\u00a0go away.<\/p>\n<p class=\"yf-1fy9kyt\">Tell your healthcare provider if you have any side effects.\u00a0<b>You can report side effects at 1-800-FDA-1088 or\u00a0<\/b><a href=\"https:\/\/www.fda.gov\/safety\/medwatch-fda-safety-information-and-adverse-event-reporting-program\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:www.fda.gov\/medwatch;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;www.fda.gov\/medwatch&quot;}\" class=\"link \">www.fda.gov\/medwatch<\/a>.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Before using<\/b>\u00a0<b>Mounjaro<\/b><\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Your healthcare provider should show you how to use<\/b>\u00a0<b>Mounjaro<\/b>\u00a0<b>before you use it for the first time.<\/b><\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Talk to your healthcare provider about low blood sugar and how to manage it.<\/b><\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>If you take birth control pills by mouth, talk to your healthcare provider before you use<\/b>\u00a0<b>Mounjaro. Birth control pills may not work as well while using<\/b>\u00a0<b>Mounjaro.<\/b>\u00a0Your healthcare provider may recommend another type of birth control for 4 weeks after you start\u00a0Mounjaro\u00a0and for 4 weeks after each increase in your dose of\u00a0Mounjaro.<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><b>Review these questions with your healthcare provider:<\/b> <br \/>\u2751 Do you have other medical conditions, including problems with your pancreas, or severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food? <br \/>\u2751 Do you take other diabetes medicines, such as insulin or\u00a0sulfonylureas? <br \/>\u2751 Do you have a history of diabetic retinopathy? <br \/>\u2751 Are you scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)? <br \/>\u2751 Are you pregnant, plan to become pregnant,\u00a0breastfeeding, or plan to breastfeed? It is not known if\u00a0Mounjaro\u00a0will harm your unborn baby.\u00a0Mounjaro may pass into your breast milk.\u00a0<br \/>\u2751 Do you take any other prescription medicines or over-the-counter drugs, vitamins, or herbal supplements?<\/p>\n<p class=\"yf-1fy9kyt\"><b>How to take<\/b><\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Read the\u00a0<b>Instructions for Use<\/b>\u00a0that come with\u00a0Mounjaro.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Use\u00a0Mounjaro\u00a0exactly as your healthcare provider says.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">A caregiver may give you\u00a0Mounjaro\u00a0injections, or you may self-inject if a healthcare provider\u00a0determines\u00a0that it is\u00a0appropriate.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Inject\u00a0Mounjaro\u00a0under the skin (subcutaneously) of your stomach (abdomen), thigh, or another person should inject in the back of the upper arm.\u00a0<b>Do not<\/b>\u00a0inject\u00a0Mounjaro\u00a0into a muscle (intramuscularly) or vein (intravenously).<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Use<\/b>\u00a0<b>Mounjaro<\/b>\u00a0<b>1 time each week, at any time of the day.<\/b><\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Do not<\/b>\u00a0mix insulin and\u00a0Mounjaro\u00a0together in the same injection.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">You may give an injection of\u00a0Mounjaro\u00a0and insulin in the same body area (such as your stomach area), but not right next to each other.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Change (rotate) your injection site with each weekly injection.\u00a0<b>Do not<\/b>\u00a0use the same site for each injection.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">If you take too much\u00a0Mounjaro, call your healthcare provider or Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><b>Learn more<\/b> <br \/>Mounjaro\u00a0is a prescription medicine available as a pre-filled single-dose pen in 2.5 mg,\u00a05 mg, 7.5 mg,\u00a010 mg,\u00a012.5 mg, or\u00a015 mg\u00a0per 0.5 mL injection. For more information, call 1-800-LillyRX (800-545-5979)\u00a0or go to\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4680912-1&amp;h=1467664514&amp;u=https%3A%2F%2Fwww.mounjaro.lilly.com%2F&amp;a=www.mounjaro.lilly.com\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:www.mounjaro.lilly.com;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;www.mounjaro.lilly.com&quot;}\" class=\"link \"><b>www.mounjaro.lilly.com<\/b><\/a><b>.<\/b><\/p>\n<p class=\"yf-1fy9kyt\">This summary provides basic information about Mounjaro but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your healthcare provider. Be sure to talk to your healthcare provider about Mounjaro and how to take it. Your healthcare provider is the best person to help you decide if Mounjaro is right for you.<\/p>\n<p class=\"yf-1fy9kyt\"><b>TR CON BS\u00a0<\/b>\u00a0<b>19DEC2025<\/b> <br \/>Mounjaro\u00ae\u00a0and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.<\/p>\n<p class=\"yf-1fy9kyt\"><b>INDICATION AND SAFETY SUMMARY WITH WARNINGS<\/b> <br \/>Foundayo\u2122 (fown-DAY-oh) is a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Warnings \u2013<\/b>\u00a0Foundayo\u00a0may cause tumors in the thyroid, including thyroid cancer. Watch for\u00a0possible symptoms, such as a lump or swelling in the neck, hoarseness, trouble swallowing, or shortness of breath. If you have any of these symptoms, tell your healthcare provider.<\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Do not use\u00a0Foundayo\u00a0if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC).<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Do not use\u00a0Foundayo\u00a0if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Do not use\u00a0Foundayo\u00a0if you have had a serious allergic reaction to\u00a0orforglipron\u00a0or any of the ingredients in\u00a0Foundayo.<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><b>Foundayo<\/b>\u00a0<b>may cause serious side effects, including:<\/b><\/p>\n<p class=\"yf-1fy9kyt\"><b>Inflammation of<\/b>\u00a0<b>the pancreas<\/b>\u00a0<b>(pancreatitis).<\/b>\u00a0Stop taking\u00a0Foundayo\u00a0and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting. Sometimes you may feel\u00a0the pain\u00a0from your abdomen to your back.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Severe stomach problems.<\/b>\u00a0Stomach problems, sometimes severe, have been reported in people who use\u00a0Foundayo. Tell your healthcare provider if you have stomach problems that are severe or will not go away.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Dehydration<\/b>\u00a0<b>leading<\/b>\u00a0<b>to kidney problems.<\/b>\u00a0Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems. It is important for you to drink fluids to help reduce your chance of dehydration. Tell your healthcare provider right away if you have nausea, vomiting, or diarrhea that does not go away.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Low blood sugar (hypoglycemia).<\/b>\u00a0Your risk for getting low blood sugar may be higher if you use\u00a0Foundayo\u00a0with medicines that can cause low blood sugar, such as\u00a0an insulin\u00a0or sulfonylurea.\u00a0<b>Signs and symptoms of low blood sugar may include<\/b>\u00a0dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, mood changes, hunger, weakness, or feeling jittery.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Serious allergic reactions.<\/b>\u00a0Stop using\u00a0Foundayo\u00a0and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching,\u00a0fainting\u00a0or feeling dizzy, or very rapid heartbeat.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Changes in vision in patients with type 2 diabetes.<\/b>\u00a0Tell your healthcare provider if you have changes in vision during treatment with\u00a0Foundayo.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Gallbladder problems.<\/b> Gallbladder problems have happened\u00a0in\u00a0some people who use\u00a0Foundayo. Tell your healthcare provider right away if you get symptoms of gallbladder problems, which may include pain in your upper stomach (abdomen), fever, yellowing of skin or eyes (jaundice), or clay-colored stools.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Food or liquid getting into the lungs during surgery or other procedures that use anesthesia or deep sleepiness (deep sedation).<\/b>\u00a0Foundayo\u00a0may increase the chance of food getting into your lungs during surgery or other procedures. Tell your healthcare providers that you are taking\u00a0Foundayo\u00a0before you are scheduled to have surgery or other procedures.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Common side effects<\/b> <br \/>The most common side effects of\u00a0Foundayo\u00a0include nausea, constipation, diarrhea, vomiting, indigestion, stomach (abdominal) pain, headache, swollen belly, feeling tired, belching, heartburn, gas, and hair loss. These are not\u00a0all the\u00a0possible side effects of\u00a0Foundayo. Talk to your healthcare provider about any side\u00a0effect\u00a0that\u00a0bothers\u00a0you or\u00a0doesn&#8217;t\u00a0go away.<\/p>\n<p class=\"yf-1fy9kyt\">Tell your doctor if you have any side effects.\u00a0<b>You can report side effects at 1-800-FDA-1088 or<\/b>\u00a0<a href=\"https:\/\/www.fda.gov\/safety\/medwatch-fda-safety-information-and-adverse-event-reporting-program\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:www.fda.gov\/medwatch;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;www.fda.gov\/medwatch&quot;}\" class=\"link \">www.fda.gov\/medwatch<\/a><b>.<\/b><\/p>\n<p class=\"yf-1fy9kyt\"><b>Before taking<\/b>\u00a0<b>Foundayo<\/b><\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Tell your healthcare provider about all the medicines you take.<\/b>\u00a0Foundayo\u00a0may affect the way some medicines work, and some medicines may affect the way\u00a0Foundayo\u00a0works.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Pregnancy Exposure Registry<\/b>: There will be a pregnancy exposure registry for women who have taken\u00a0Foundayo\u00a0during pregnancy. The purpose of this registry is to collect information about the health\u00a0of you and\u00a0your baby. Talk to your healthcare provider about how you can take part in this registry, or you may contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979).<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>If you take birth control pills by mouth, talk to your healthcare provider before you take<\/b>\u00a0<b>Foundayo. Birth control pills may not work as well while taking<\/b>\u00a0<b>Foundayo.<\/b>\u00a0Your healthcare provider may recommend another type of birth control for 30 days after starting\u00a0Foundayo\u00a0and for\u00a030 days\u00a0after each dose increase of\u00a0Foundayo.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Talk to your healthcare provider about low blood sugar and how to manage it.<\/b>\u00a0Tell your healthcare provider if you are taking medicines to treat diabetes including\u00a0an insulin\u00a0or sulfonylurea.<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><b>Review these questions with your healthcare provider:<\/b> <br \/>\u2751 Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your liver, severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food? <br \/>\u2751 Do you have a history of diabetic retinopathy? <br \/>\u2751 Are you scheduled to have surgery or other procedures that use anesthesia or deep sleepiness (deep sedation)? <br \/>\u2751 Are you pregnant or plan to become pregnant? Foundayo may harm your unborn baby.\u00a0<br \/>\u2751 Are you\u00a0breastfeeding or plan to breastfeed? Breastfeeding is not recommended during treatment with\u00a0Foundayo. <br \/>\u2751 Do you take any other prescriptions or over-the-counter medicines, vitamins, or herbal supplements?<\/p>\n<p class=\"yf-1fy9kyt\"><b>How to take<\/b><\/p>\n<ul class=\"yf-1p2hw41\">\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Take\u00a0Foundayo\u00a0exactly as your healthcare provider tells you to.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Use\u00a0Foundayo\u00a0with a\u00a0reduced-calorie\u00a0diet and increased physical activity.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Take\u00a0Foundayo\u00a0by mouth 1 time each day, with or without food.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">Swallow tablets whole. Do not break, crush, or chew the tablet.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">If you miss a dose, take it as soon as possible.\u00a0<b>Do not<\/b>\u00a0take\u00a0<b>2<\/b>\u00a0doses of\u00a0Foundayo\u00a0in\u00a0the same day.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\"><b>Do not take more than 1 tablet per day.<\/b><\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">If you miss taking\u00a0Foundayo\u00a0for 7 or more days in a row, call your healthcare provider to talk about how to restart your treatment.<\/p>\n<\/li>\n<li class=\"yf-1p2hw41\">\n<p class=\"yf-1fy9kyt\">If you take too\u00a0much\u00a0Foundayo, call your healthcare provider or Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.<\/p>\n<\/li>\n<\/ul>\n<p class=\"yf-1fy9kyt\"><b>Learn more<\/b> <br \/>Foundayo\u00a0is a prescription medicine\u00a0available in 0.8 mg, 2.5 mg,\u00a05.5 mg,\u00a09 mg,\u00a014.5 mg, or\u00a017.2 mg\u00a0oral tablets. For more information, call 1-800-545-5979\u00a0or go\u00a0to\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4680912-1&amp;h=2254318754&amp;u=https%3A%2F%2Ffoundayo.lilly.com%2F&amp;a=foundayo.lilly.com\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:foundayo.lilly.com;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;foundayo.lilly.com&quot;}\" class=\"link \"><b>foundayo.lilly.com<\/b><\/a><b>.<\/b><\/p>\n<p class=\"yf-1fy9kyt\">This summary provides basic information about\u00a0Foundayo\u00a0but does not include all information known about this medicine. Read the information that comes with your prescription each time your prescription is filled. This information does not take the place of talking with your doctor. Be sure to talk to your doctor or other healthcare provider about\u00a0Foundayo\u00a0and how to take it. Your doctor is the best person to help you decide if\u00a0Foundayo is right for you.<\/p>\n<p class=\"yf-1fy9kyt\"><b>OG CON BS APR2026<\/b> <br \/>Foundayo\u2122\u00a0is a trademark of Eli Lilly and Company.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Endnotes and References<\/b> <br \/>1. Based on IQVIA\u00ae National Prescription Audit Data as of April 16, 2026.\u00a0<br \/>2. Data based on IQVIA\u00ae APLD Claims Data as of January 23, 2026. <br \/>3. Ma X, Liu R, Pratt EJ, Benson CT,\u00a0Bhattachar\u00a0SN, Sloop KW. Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered\u00a0Orforglipron\u00a0(LY3502970), a Non-peptide GLP-1 Receptor Agonist. Diabetes Ther. 2024 Apr;15(4):819-832.\u00a0<a href=\"https:\/\/link.springer.com\/10.1007\/s13300-024-01554-1\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:https:\/\/doi.org\/10.1007\/s13300-024-01554-1;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;https&quot;}\" class=\"link \">https:\/\/doi.org\/10.1007\/s13300-024-01554-1<\/a>.\u00a0Epub\u00a02024 Feb 24. PMID: 38402332; PMCID: PMC10951152.<\/p>\n<p class=\"yf-1fy9kyt\"><b>About Lilly<\/b><br \/>Lilly is a medicine company turning science into healing to make life better for people around the world. We&#8217;ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world&#8217;s most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer&#8217;s disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we&#8217;re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4680912-1&amp;h=358516135&amp;u=https%3A%2F%2Fwww.lilly.com%2F%3Futm_source%3Dpr%26utm_medium%3Dreferral%26utm_campaign%3Dpr_boilerplate&amp;a=Lilly.com\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Lilly.com;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Lilly.com&quot;}\" class=\"link \">Lilly.com<\/a> and\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4680912-1&amp;h=1785761359&amp;u=https%3A%2F%2Fwww.lilly.com%2Fnews%3Futm_source%3Dpr%26utm_medium%3Dreferral%26utm_campaign%3Dpr_boilerplate&amp;a=Lilly.com%2Fnews\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Lilly.com\/news;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Lilly.com\/news&quot;}\" class=\"link \">Lilly.com\/news<\/a>, or follow us on <a href=\"https:\/\/www.facebook.com\/elilillyandco\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Facebook;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Facebook&quot;}\" class=\"link \">Facebook<\/a>, <a href=\"https:\/\/www.instagram.com\/elilillyco\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Instagram;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Instagram&quot;}\" class=\"link \">Instagram<\/a>, and <a href=\"https:\/\/www.linkedin.com\/company\/eli-lilly-and-company\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:LinkedIn;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;LinkedIn&quot;}\" class=\"link \">LinkedIn<\/a>. C-LLY<\/p>\n<p class=\"yf-1fy9kyt\"><b>Trademarks and Trade Names <br \/><\/b>All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are referenced in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the \u00ae and \u2122 symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company&#8217;s or their rights thereto. We do not intend the use or display of other companies&#8217; trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.<\/p>\n<p class=\"yf-1fy9kyt\"><b>Cautionary Statement Regarding Forward-Looking Statements<\/b> <br \/>This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995), including about planned capital investments in new manufacturing capacity, production and delivery of medicines, including Foundayo\u00a0and\u00a0retatrutide, hiring and related initiatives and the economic impact thereof and reflects Lilly&#8217;s current beliefs and expectations. However, as with any such undertaking, there are substantial risks and uncertainties in the manufacturing process, development and commercialization of pharmaceutical products any of which could impact the overall commercial success of our products, and as related to cost, completion timing, expected capacity, personnel, and other factors which could impact expected benefits of the capacity expansion and related initiatives. For further discussion of risks and uncertainties relevant to Lilly&#8217;s business that could cause actual results to differ from Lilly&#8217;s expectations, see Lilly&#8217;s Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.<\/p>\n<p class=\"yf-1fy9kyt\">\u00a0<\/p>\n<p>   <a href=\"https:\/\/mma.prnewswire.com\/media\/133140\/eli_lilly_and_company_logo.html\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)\" loading=\"lazy\" height=\"219\" width=\"400\" class=\"yf-lglytj loader\"\/><\/a> Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)     <\/p>\n<p class=\"yf-1fy9kyt\">\u00a0<\/p>\n<p>   <img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"Cision\" loading=\"lazy\" height=\"12\" width=\"12\" class=\"yf-lglytj loader\"\/> Cision     <\/p>\n<p class=\"yf-1fy9kyt\">View original content to download multimedia:<a href=\"https:\/\/www.prnewswire.com\/news-releases\/lilly-commits-additional-4-5-billion-across-indiana-manufacturing-sites-opens-first-dedicated-genetic-medicine-facility-302763332.html\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:https:\/\/www.prnewswire.com\/news-releases\/lilly-commits-additional-4-5-billion-across-indiana-manufacturing-sites-opens-first-dedicated-genetic-medicine-facility-302763332.html;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;https&quot;}\" class=\"link \">https:\/\/www.prnewswire.com\/news-releases\/lilly-commits-additional-4-5-billion-across-indiana-manufacturing-sites-opens-first-dedicated-genetic-medicine-facility-302763332.html<\/a><\/p>\n<p> <script async src=\"\/\/www.instagram.com\/embed.js\"><\/script><\/p>\n","protected":false},"excerpt":{"rendered":"&#8220;This expansion reflects the strength of a long-standing partnership between Lilly and the state of Indiana \u2013 one&hellip;\n","protected":false},"author":2,"featured_media":942888,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4316],"tags":[51272,263385,105,4348,109129,263386,5332,16,15],"class_list":{"0":"post-942887","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-eli-lilly-and-company","9":"tag-gallbladder-problems","10":"tag-health","11":"tag-healthcare","12":"tag-healthcare-provider","13":"tag-kidney-problems","14":"tag-side-effects","15":"tag-uk","16":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/116531016827189382","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/942887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=942887"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/942887\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/942888"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=942887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=942887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=942887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}